Logo image of OTIC

OTONOMY INC (OTIC) Stock Fundamental Analysis

USA - NASDAQ:OTIC - US68906L1052 - Common Stock

0.077 USD
-0.01 (-11.19%)
Last: 12/22/2022, 8:00:02 PM
0.083 USD
+0.01 (+7.79%)
After Hours: 12/22/2022, 8:00:02 PM
Fundamental Rating

1

OTIC gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 192 industry peers in the Pharmaceuticals industry. OTIC has a bad profitability rating. Also its financial health evaluation is rather negative. OTIC is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

OTIC had negative earnings in the past year.
In the past year OTIC has reported a negative cash flow from operations.
OTIC Yearly Net Income VS EBIT VS OCF VS FCFOTIC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 -20M -40M -60M -80M -100M

1.2 Ratios

OTIC has negative profitability rations, so we won't be analyzing them here.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
OTIC Yearly ROA, ROE, ROICOTIC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 -20 -40 -60 -80 -100

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for OTIC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
OTIC Yearly Profit, Operating, Gross MarginsOTIC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 -10K -20K -30K -40K

More info and screens

2

2. Health

2.1 Basic Checks

OTIC does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for OTIC has been increased compared to 1 year ago.
The debt/assets ratio for OTIC is higher compared to a year ago.
OTIC Yearly Shares OutstandingOTIC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 10M 20M 30M 40M 50M
OTIC Yearly Total Debt VS Total AssetsOTIC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 50M 100M 150M 200M

2.2 Solvency

Based on the Altman-Z score of -16.93, we must say that OTIC is in the distress zone and has some risk of bankruptcy.
OTIC's Altman-Z score of -16.93 is on the low side compared to the rest of the industry. OTIC is outperformed by 90.99% of its industry peers.
A Debt/Equity ratio of 0.01 indicates that OTIC is not too dependend on debt financing.
OTIC has a Debt to Equity ratio of 0.01. This is comparable to the rest of the industry: OTIC outperforms 49.10% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z -16.93
ROIC/WACCN/A
WACC10.41%
OTIC Yearly LT Debt VS Equity VS FCFOTIC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 0 50M -50M 100M 150M

2.3 Liquidity

OTIC has a Current Ratio of 1.74. This is a normal value and indicates that OTIC is financially healthy and should not expect problems in meeting its short term obligations.
OTIC's Current ratio of 1.74 is on the low side compared to the rest of the industry. OTIC is outperformed by 75.23% of its industry peers.
A Quick Ratio of 1.74 indicates that OTIC should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.74, OTIC is doing worse than 69.82% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.74
Quick Ratio 1.74
OTIC Yearly Current Assets VS Current LiabilitesOTIC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 50M 100M 150M 200M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 4.94% over the past year.
Looking at the last year, OTIC shows a very negative growth in Revenue. The Revenue has decreased by -100.00% in the last year.
The Revenue for OTIC have been decreasing by -28.73% on average. This is quite bad
EPS 1Y (TTM)4.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%5.26%
Revenue 1Y (TTM)-100%
Revenue growth 3Y-44.97%
Revenue growth 5Y-28.73%
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 2.08% on average over the next years.
The Revenue is expected to decrease by -14.87% on average over the next years. This is quite bad
EPS Next Y3.04%
EPS Next 2Y10.42%
EPS Next 3Y-0.66%
EPS Next 5Y2.08%
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3Y-25.99%
Revenue Next 5Y-14.87%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
OTIC Yearly Revenue VS EstimatesOTIC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 500K 1M
OTIC Yearly EPS VS EstimatesOTIC Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 -1 -2 -3 -4

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for OTIC. In the last year negative earnings were reported.
Also next year OTIC is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OTIC Price Earnings VS Forward Price EarningsOTIC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OTIC Per share dataOTIC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 -0.4 -0.6 -0.8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y10.42%
EPS Next 3Y-0.66%

More info and screens

0

5. Dividend

5.1 Amount

OTIC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

OTONOMY INC

NASDAQ:OTIC (12/22/2022, 8:00:02 PM)

After market: 0.083 +0.01 (+7.79%)

0.077

-0.01 (-11.19%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)11-10 2022-11-10/amc
Earnings (Next)02-27 2023-02-27
Inst Owners0%
Inst Owner Change0%
Ins Owners10.54%
Ins Owner Change0%
Market Cap4.40M
Revenue(TTM)N/A
Net Income(TTM)-52260000
Analysts77.78
Price Target9.18 (11822.08%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.99%
Min EPS beat(2)6.86%
Max EPS beat(2)7.12%
EPS beat(4)3
Avg EPS beat(4)2.53%
Min EPS beat(4)-7.44%
Max EPS beat(4)7.12%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)N/A
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-4.52%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.21
P/tB 0.21
EV/EBITDA N/A
EPS(TTM)-0.77
EYN/A
EPS(NY)-0.63
Fwd EYN/A
FCF(TTM)-0.82
FCFYN/A
OCF(TTM)-0.82
OCFYN/A
SpS0
BVpS0.37
TBVpS0.37
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 43.04%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.74
Quick Ratio 1.74
Altman-Z -16.93
F-Score2
WACC10.41%
ROIC/WACCN/A
Cap/Depr(3y)35.87%
Cap/Depr(5y)49.46%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)4.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%5.26%
EPS Next Y3.04%
EPS Next 2Y10.42%
EPS Next 3Y-0.66%
EPS Next 5Y2.08%
Revenue 1Y (TTM)-100%
Revenue growth 3Y-44.97%
Revenue growth 5Y-28.73%
Sales Q2Q%N/A
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3Y-25.99%
Revenue Next 5Y-14.87%
EBIT growth 1Y-8.95%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-22.84%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-23.44%
OCF growth 3YN/A
OCF growth 5YN/A

OTONOMY INC / OTIC FAQ

What is the fundamental rating for OTIC stock?

ChartMill assigns a fundamental rating of 1 / 10 to OTIC.


What is the valuation status of OTONOMY INC (OTIC) stock?

ChartMill assigns a valuation rating of 3 / 10 to OTONOMY INC (OTIC). This can be considered as Overvalued.


What is the profitability of OTIC stock?

OTONOMY INC (OTIC) has a profitability rating of 0 / 10.


Can you provide the expected EPS growth for OTIC stock?

The Earnings per Share (EPS) of OTONOMY INC (OTIC) is expected to grow by 3.04% in the next year.